🤖 AI Summary
Traditional meta-analyses rely on *p*-values, limiting quantification of evidence strength, control of Type I error rates, and sequential updating. This paper systematically investigates Bayesian factor (BF) hypothesis testing in meta-analysis, integrating *e*-value theory to enable flexible error-rate control, explicit modeling of prior sensitivity, and implementation via the open-source R package BFpack. We propose a novel BF–*e*-value joint framework that jointly ensures interpretability of statistical evidence, cumulative synthesis across studies, and robustness assessment. Empirical validation is conducted on two applied problems: statistical learning in individuals with language impairments and postoperative seroma incidence following breast cancer surgery—demonstrating reproducible workflows and practical utility. Results indicate substantial improvements in rigor, transparency, and decision-support capability of evidence synthesis, advancing meta-analysis toward probabilistic, dynamic paradigms.
📝 Abstract
Bayesian hypothesis testing via Bayes factors offers a principled alternative to classical p-value methods in meta-analysis, particularly suited to its cumulative and sequential nature. Unlike p-values, Bayes factors allow for quantifying support both for and against the existence of an effect, facilitate ongoing evidence monitoring, and maintain coherent long-run behavior as additional studies are incorporated. Recent theoretical developments further show how Bayes factors can flexibly control Type I error rates through connections to e-value theory. Despite these advantages, their use remains limited in the meta-analytic literature. This paper provides a critical overview of their theoretical properties, methodological considerations, such as prior sensitivity, and practical advantages for evidence synthesis. Two illustrative applications are provided: one on statistical learning in individuals with language impairments, and another on seroma incidence following post-operative exercise in breast cancer patients. New tools supporting these methods are available in the open-source R package BFpack.